We are live on
!
Find out more
CG
Cutler Group Portfolio holdings
AUM
$307M
1-Year Est. Return
45.11%
This Fund
S&P 500
This Quarter
Est. Return
+7.53%
1 Year Est. Return
+45.11%
3 Year Est. Return
+57.72%
5 Year Est. Return
+302.49%
10 Year Est. Return
–
AUM
$2.71B
AUM Growth
+$307M
(+13%)
Cap. Flow
+$2.8B
Cap. Flow
% of AUM
103.22%
Top 10 Holdings %
Top 10 Hldgs %
23.01%
Holding
7,805
New
1,401
Increased
2,380
Reduced
2,248
Closed
1,408
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$125M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$85.9M |
| 3 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$31.6M |
| 4 |
NVIDIA
NVDA
|
+$29M |
| 5 |
Biogen
BIIB
|
+$23.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$79.3M |
| 2 |
Apple
AAPL
|
+$77.9M |
| 3 |
iShares Russell 1000 ETF
IWB
|
+$47.1M |
| 4 |
CEO
CNOOC Limited
CEO
|
+$17.6M |
| 5 |
Meta Platforms (Facebook)
META
|
+$17.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 10.94% |
| 2 | Technology | 10.44% |
| 3 | Healthcare | 6.66% |
| 4 | Communication Services | 6.39% |
| 5 | Financials | 5.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TESO
4026
DELISTED
Tesco Corp
TESO
| $12K | ﹤0.01% |
2,768
+1,800
| +186% | +$9.93K |
|
|
CBPO
4027
CALL
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $12K | ﹤0.01% |
11,500
+600
| +6% | +$67.1K |
|
|
KATE
4028
PUT
DELISTED
Kate Spade & Company
KATE
| $12K | ﹤0.01% |
72,600
+61,400
| +548% | +$1.13M |
|
|
CA
4029
PUT
DELISTED
CA, Inc.
CA
| $12K | ﹤0.01% |
+25,200
| New | +$815K |
|
|
CMO
4030
DELISTED
Capstead Mortgage Corp.
CMO
| $12K | ﹤0.01% |
1,240
-5,285
| -81% | -$56.6K |
|
|
CKH
4031
PUT
DELISTED
Seacor Holdings Inc.
CKH
| $12K | ﹤0.01% |
+1,137
| New | +$60.2K |
|
|
CCIH
4032
DELISTED
Chinacache International Holdings Ltd
CCIH
| $12K | ﹤0.01% |
10,786
+1,000
| +10% | +$1.23K |
|
|
GG
4033
CALL
DELISTED
Goldcorp Inc
GG
| $12K | ﹤0.01% |
83,400
-96,100
| -54% | -$1.34M |
|
|
ARLZ
4034
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
| $12K | ﹤0.01% |
9,303
-29,419
| -76% | -$42.5K |
|
|
SGY
4035
DELISTED
Stone Energy
SGY
| $12K | ﹤0.01% |
+700
| New | +$15K |
|
|
ALDW
4036
PUT
DELISTED
Alon USA Partners LP
ALDW
| $12K | ﹤0.01% |
12,900
+10,900
| +545% | +$111K |
|
|
SSRI
4037
DELISTED
Silver Standard Resources
SSRI
| $12K | ﹤0.01% |
1,282
-9,707
| -88% | -$97.5K |
|
4038
CALL
Agios Pharmaceuticals
AGIO
$1.79B
| $11K | ﹤0.01% |
3,800
-36,700
| -91% | -$1.88M |
|
4039
CALL
Assured Guaranty
AGO
$3.66B
| $11K | ﹤0.01% |
6,700
+5,700
| +570% | +$225K |
|
4040
PUT
Assurant
AIZ
$13.8B
| $11K | ﹤0.01% |
+25,600
| New | +$2.55M |
|
4041
PUT
Arista Networks
ANET
$227B
| $11K | ﹤0.01% |
179,200
-67,200
| -27% | -$609K |
|
4042
AngioDynamics
ANGO
$611M
| $11K | ﹤0.01% |
736
-964
| -57% | -$15.2K |
|
4043
Apogee Enterprises
APOG
$826M
| $11K | ﹤0.01% |
195
-442
| -69% | -$24.3K |
|
4044
ArcBest
ARCB
$3.23B
| $11K | ﹤0.01% |
+572
| New | +$12.4K |
|
4045
CALL
Axogen
AXGN
$2.27B
| $11K | ﹤0.01% |
2,100
| – | – |
|
4046
PUT
Axalta
AXTA
$7.66B
| $11K | ﹤0.01% |
24,600
-29,300
| -54% | -$936K |
|
4047
CALL
BGC Group
BGC
$5.45B
| $11K | ﹤0.01% |
+27,057
| New | +$203K |
|
4048
PUT
Brookfield
BN
$104B
| $11K | ﹤0.01% |
4,204
-1,682
| -29% | -$22.6K |
|
4049
PUT
Brixmor Property Group
BRX
$9.67B
| $11K | ﹤0.01% |
1,900
-3,000
| -61% | -$58.1K |
|
4050
PUT
British American Tobacco
BTI
$131B
| $11K | ﹤0.01% |
+4,900
| New | +$340K |
|
Similar funds
MFF
HCM
CSC
ORPU
SFG
RG
FW
APWM
Cutler Group's Q2 2017 Portfolio in Review
As of Q2 2017, Cutler Group held 7,805 positions worth $2.71B, up 13% from $2.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Cutler Group deployed $2.8B of net new capital in Q2 2017, opening 1,401 new positions and adding to 2,380 existing holdings. Its largest new stake was iShares US Medical Devices ETF: 316,230 shares worth $8.78M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 11% of assets, up from 6.9% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $77.9M trimmed.
- Cutler Group's largest Q2 2017 buy was iShares US Medical Devices ETF: 316,230 shares worth $8.78M.
- Cutler Group added most to Amazon in Q2 2017, an estimated $125M increase.
- Cutler Group's biggest Q2 2017 reduction was Apple, cutting an estimated $77.9M.
- Cutler Group fully exited Invesco QQQ Trust in Q2 2017, selling an estimated $79.3M.
- Cutler Group's ten largest holdings make up 23% of its $2.71B portfolio in Q2 2017.
- Cutler Group opened 1,401 new positions and closed 1,408 in Q2 2017.
- Cutler Group's portfolio value rose 13% quarter-over-quarter to $2.71B.
Based on Cutler Group's 13F filing for Q2 2017, filed 11 Jul 2017.